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Summary Statement 
The acid sphinogymelinase trafficking protein sortilin is modulated by but not requisite for 




Chlamydia species are obligate intracellular pathogens that have a major impact on human 
health. The bacterium replicates within an intracellular niche called an inclusion and is 
thought to rely heavily on host-derived proteins and lipids, including ceramide. Sortilin is a 
transmembrane receptor implicated in the trafficking of acid sphingomyelinase which is 
responsible for catalysing the breakdown of sphingomyelin to ceramide. In this study, we 
examined the role of sortilin in Chlamydia trachomatis L2 pathogenesis. Immunoblotting and 
immunocytochemistry analysis revealed that endogenous sortilin is not only associated with 
the inclusion but the protein levels increase in infected cells. RNAi-mediated depletion of 
sortilin, however, had no detectable impact on ceramide delivery to the inclusion or the 
production of infectious progeny. This study demonstrates that whilst Chlamydia redirects 
sortilin trafficking to the chlamydial inclusion, this pathway is not requisite for the 





Chlamydia trachomatis (C. trachomatis) is the most prevalent bacterial sexually transmitted 
infection amongst humans and the leading cause non-congenital blindness worldwide 
(Belland et al., 2004). As an obligate intracellular pathogen, C. trachomatis passes its entire 
lifecycle within an intracellular membrane-bound vacuole called the inclusion. The capacity 
to create and maintain such a specialised replicative niche is an important virulence property 
for many intracellular pathogens (Scott et al., 2002, Vergne et al., 2005, Dupont et al., 2009). 
To facilitate the growth of the inclusion and to ensure delivery of nutrients to the pathogen, 
Chlamydia manipulates the membrane trafficking pathways of the host cell (Elwell and 
Engel, 2012). Notably, Chlamydia relies on host-derived lipids for survival such as 
sphingomyelin, phosphatidylcholine, phosphatidylinositol and cholesterol (Hatch and 
McClarty, 1998, Wylie et al., 1997, Hackstadt et al., 1995, Carabeo et al., 2003).  
Using a short chain fluorescent analogue of ceramide (C6-NBD-ceramide), Hackstadt and co-
workers demonstrated the conversion of ceramide to sphingomyelin in the Golgi and 
subsequent delivery and accumulation of the fluorescent lipid within the inclusion as early as 
2 h p.i. (Hackstadt et al., 1996). Treatment with myriocin, a potent inhibitor of serine 
palmitoyltransferase, the initial enzyme in the biosynthesis of sphingomyelin (Hanada et al., 
2000) perturbs homotypic fusion of chlamydial inclusions as well as inclusion membrane 
stability (Robertson et al., 2009). Concurrent treatment with dihydroceramide or sphingosine 
reversed this phenotype highlighting the requirement for ceramide and/or sphingomyelin in 
chlamydial biology (ref? maybe  presumably it is still robertson). Chlamydia are thought to 
acquire sphingomyelin by intercepting sphingomyelin-containing Golgi-derived exocytic 
vesicles destined for the plasma membrane (Hackstadt et al., 1996); fusion of multi-vescular 
bodies with the inclusion (Beatty, 2008, Beatty, 2006) or via non-vesicular means through the 
hijacking of the ceramide transfer protein (CERT) (Derre et al., 2011). With regards to the 
latter, Elwell and colleagues propose that C. trachomatis recruits CERT, its ER binding 
partner, VAP-A, and the sphingomyelin synthases, SMS1 and SMS2, to establish an “on-site 
sphingomyelin biosynthetic factory” at or near the inclusion (Elwell et al., 2011). What is not 
clear is where the sphingomyelin precursor, ceramide, to support this system is sourced from. 
The constitutive degradation of sphingolipids within the eukaryotic cell takes place in multi-
vesicular bodies where sphingomyelin is converted to ceramide by acid sphingomyelinase 
(ASM) (Lansmann et al., 2003). ASM is demonstrated to play a central role in the cellular 
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response to a variety of cellular stresses, including environmental insults, apoptosis and 
pathogen infection (Smith and Schuchman, 2008). Sortilin is a transmembrane protein 
required for the trafficking of soluble ASM within the endosome/lysosome system (Willnow 
et al., 2008, Wahe et al., 2010). We speculated that sortilin-based trafficking of ASM may 
contribute to the supply of ceramide to the on-site sphingomyelin biosynthetic factory utilised 
by Chlamydia. We found that C. trachomatis L2 subverts the trafficking of sortilin to the 
inclusion leading to an increase in sortilin concentrations in infected cells. RNAi-mediated 
depletion of sortilin had no significant impact on chlamydial inclusion expansion or 





Sortilin is upregulated in C. trachomatis L2 infected cells and is associated with the 
chlamydial inclusion 
To investigate a role for sortilin in Chlamydia trachomatis L2 (CTL2) infection, Western 
immunoblotting was initially performed to monitor the levels of sortilin in infected cells. 
Western immunoblotting of HeLa cells infected with CTL2 (MOI ~0.5) revealed an increase 
in total cellular sortilin levels from 12 h p.i., with an approximately two-fold increase 
observed by 48 h p.i. relative to uninfected cells cultured under the same conditions (Fig. 1A, 
B). To determine if sortilin is associated with the limiting membrane of the chlamydial 
inclusion throughout the course of infection, indirect immunofluorescence was performed 
using anti-sortilin antibodies to examine the subcellular distribution of sortilin in infected 
cells. mCherry-Rab25, a prominent marker of the chlamydial inclusion (Fig. S1), expressing 
HeLa cells were infected with CTL2 and fixed at intervals of 12 h. The samples were 
immunolabeled with anti-sortilin antibodies, followed by a fluorescent-conjugated secondary 
antibody, counter-stained with DAPI and examined using confocal microscopy (Fig. 2A). 
Consistent with previously published studies, in uninfected cells the majority of the 
endogenous sortilin-labelling was observed to localise to the perinuclear region of the cell, 
within the Golgi and in vesicles dispersed throughout the cytoplasm, (Kwon and Christian, 
2011, Ni and Morales, 2006) presenting little overlap with mCherry-Rab25. During a 
chlamydial infection, however, endogenous sortilin is localised to the mCherry-Rab25-
positive inclusions from 12 h p.i. As the infection progressed, sortilin remained associated 
with the inclusion. Therefore, sortilin is efficiently transported to and remains associated with 
the chlamydial inclusion throughout the infection. 
Ceramide delivery to the inclusion is unaffected by depletion of sortilin 
To determine if delivery of sortilin to the chlamydial inclusion is required for infection 
progression, five shRNA-sortilin knockdown HeLa cell-lines were generated. Western 
immunoblotting confirmed a >70% decrease in endogenous sortilin in 4 of these lines when 
compared with non-silencing control cells (Fig. 3A). BODIPY-FL-ceramide was used to 
monitor delivery of ceramide and its metabolites, which include sphingomyelin and 
glucosylceramide, in living cells using time-lapse videomicroscopy of sortilin knockdown 
cells infected with CTL2 (MOI ~0.5) for 23 h. Initially the inclusion is void of any BODIPY-
FL-ceramide or TurboGFP fluorescence (shRNA reporter), highlighting the barrier function 
of the inclusion membrane. By following the fluorescent ceramide analogue, we observe the 
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rapid transportation of the lipid, first to the Golgi, and the subsequent accumulation of 
ceramide within the inclusion membrane and incorporation into the bacteria (Fig. 3B). 
Quantification of the accumulated fluorescent intensity within the inclusion over a period of 4 
h revealed no detectable difference between the control and sortilin knockdown cells (Fig. 
3C) confirming that delivery of BODIPY-FL-ceramide and its metabolites from the Golgi to 
the inclusion still occurs efficiently in these cells and that CTL2 is readily able to replicate. 
Sortilin depletion does not impact the growth of Chlamydia nor its intracellular 
development 
Sortilin is required for the efficient trafficking of soluble cargo like ASM from the Golgi to 
endosomes and in cells depleted for sortilin the intracellular trafficking of ASM is impaired 
(Wahe et al., 2010, Ni and Morales, 2006). Delivery of ASM to the chlamydial inclusion 
would be required for the bacteria to gain access to ceramide generated from the conversion 
of sphingomyelin, a lipid transported to the inclusion from the Golgi (Hackstadt et al., 1995, 
Elwell et al., 2011). An infectious progeny assay was performed to assess the impact of 
sortilin knockdown upon the intracellular development of CTL2 using the 4 most 
significantly depleted sortilin knockdown cell lines. Briefly, control and sortilin knockdown 
cells were infected with GFP-expressing CTL2 for 48 h before lysing the cells. The lysates 
were then subjected to serial dilution and the diluents used to infect a new population of 
mCherry-Rab25 expressing HeLa cells for 24 h before being fixed, DAPI labelled and 
imaged using a Nikon Deconvolution microscope. We observed no significant impact in the 
growth of the primary inclusions or upon the development of infectious progeny (Fig. 4), 
implying that sortilin dependent protein trafficking is not requisite for the intracellular 
development of C. trachomatis L2. 
Chlamydia infection stabilises cellular sortilin concentrations 
To further examine why RNAi-mediated depletion of sortilin had no impact on the 
intracellular growth and development of CTL2, we monitored the levels of sortilin in the two 
most significantly depleted knockdown lines throughout the course of infection. Surprisingly, 
at 24 h p.i., sortilin levels in both knockdown lines had increased to levels comparable with 
control cells. This increase in sortilin levels was maintained throughout the infection (Fig. 
5A, B). Analysis of sortilin mRNA levels by RT-PCR revealed no change during infection 
(Fig. 5C) suggesting that the observed increase in sortilin protein levels is a consequence of 




Whilst living within a membrane-bound vacuole provides protection from the host cell’s 
antimicrobial defence systems it also presents inherent challenges, including the need to 
remodel the host’s membrane trafficking pathways generate a replicative niche that will 
expand and provide essential nutrients to support replication. The earliest studies of lipid 
acquisition by Chlamydia demonstrated that it is capable of acquiring lipids from the Golgi 
(Hackstadt et al., 1996, Hackstadt et al., 1995).  However, when infected cells were treated 
with Brefeldin A, an inhibitor of protein trafficking from the endoplasmic reticulum to the 
Golgi, only expansion of the inclusion membrane was impaired but not chlamydial growth or 
development (Hackstadt et al., 1996). This suggests that Chlamydia may be capable of 
acquiring host lipids required for replication from multiple sources.  
Sphingomyelin is important for chlamydial growth and development. When infected cells are 
treated with myricon, a potent inhibitor of serine palmitoyltransferase, the initial enzyme in 
the biosynthesis of sphingomyelin, multiple small inclusions are observed suggesting host 
cell sphingomyelin is required for the homotypic fusion of inclusions (Robertson et al., 
2009). Here we reveal that sortilin, which is responsible for transporting ASM to endosomes, 
is associated with the chlamydial inclusion (Fig. 1) and that sortilin levels increase 
dramatically through the course of a C. trachomatis L2 infection. To dissect the role of 
sortilin in the context of a chlamydial infection, cells were depleted of endogenous sortilin 
using RNAi. When infected knockdown cells were treated with BODIPY-FL-ceramide, no 
discernible differences in its delivery to the inclusion when compared to control cells. Further 
no impact on the development and production of infectious progeny was observed. These 
results suggest that the acquisition of ceramide, generated from sphingomyelin transported 
from the Golgi, by Chlamydia is independent of sortilin and the cargo proteins, including 
ASM, that it traffics. Indeed, ceramide acquisition by Chlamydia has been previously linked 
to CERT (Derre et al., 2011), Golgi fragmentation (Heuer et al., 2009) or interception of 
vesicles from the Golgi (Derre et al., 2011, Heuer et al., 2009, Hackstadt et al., 1996).  
Further investigation revealed that when sortilin knockdown cells are infected with C. 
trachomatis L2, the protein levels of sortilin increased during the infection to levels similar to 
that of control cells. RT-PCR revealed no changes in sortilin mRNA levels, in either infected 
sortilin knockdown or control cells, indicating that sortilin transcriptional activity is not 
altered by the infection. Therefore, the increase in sortilin protein concentration observed in 
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infected cells is likely a consequence of sequestration of sortilin within the inclusion. Sortilin 
sequestered within the chlamydial inclusion will not be exposed to degradative lysosomes 
preventing its normal turnover and newly synthesised sortilin will continue to be delivered to 
the inclusion from the Golgi. The resultant net increase in sortilin levels in spite of the 
introduced shRNAs indicate that RNAi-mediated depletion of sortilin is therefore unlikely to 
be an adequate tool for dissecting its possible role in chlamydial development. Normally 
sortilin is retrieved from the endosomal compartments to the Golgi via a retromer dependent 
retrograde trafficking pathway. While retromer was recently identified as enriched 
components on isolated C. trachomatis inclusions (Aeberhard et al., 2015), it remains 
unknown whether it forms functional transport carriers from the inclusion. 
The possibility of functional redundancy in the trafficking of ASM also remains. Wahe et al. 
(2010) reported a significant reduction but not complete loss of prosaposin and ASM from 
phagosomes isolated from Sortilin-/- macrophages, which is consistent with an alternate 
pathway for trafficking of these proteins to the phagosomes. The Mannose-6 Phosphate 
Receptor also binds ASM and delivers it to endosomes (Ni and Morales, 2006) and has not 
only been associated with the chlamydial inclusion but has been proposed to be required for 
the attachment and internalisation of the pathogen (vanOoij et al., 1997, Puolakkainen et al., 
2005). Its presence on the chlamydial inclusion may explain why depleting sortilin alone had 
no impact on the infection. Targeted disruption of sortilin and/or Mannose-6 Phosphate 




Materials and Methods 
Constructs and reagents 
Rabbit-polyclonal antibodies against sortilin (Abcam, ab16640, 1:1000), rabbit-monoclonal 
antibody against chlamydial protease/chaperone protein, CtHtrA (Huston et al., 2008, 1:1000) 
and mouse monoclonal antibodies against beta-actin (Merck Millipore, MAB1501, 1:1000) 
were used. Secondary antibodies were purchased from Molecular Probes (Life Technologies) 
and Li-Cor Bioscience. mCherry-Rab25 was obtained by performing restriction digest using 
restriction enzymes BamHI and EcoRI on GFP-Rab25 (Casanova et al., 1999) to obtain the 
open reading frame of Rab25 and subcloned into mCherry-C1 following standard protocols. 
Stably expressing mCherry-Rab25 HeLa cells were generated by transient transfection of 
mCherry-Rab25 into HeLa cells using Lipofectamine 2000 as per manufacturer’s instruction 
(Invitrogen). Transfected cells were selected using 400 µg/ml of G418 over a period of 14 
days to generate stable cell lines expressing mCherry Rab25.  pGIPZ small hairpin RNA 
(shRNA) plasmids (Thermo Scientific) used included non-silencing control shRNA: 
RHS4346; human sortilin shRNAs (shRNA #1: V2LHS_31931, shRNA #2: V2LHS_31928, 
shRNA #3: V3LHS_359770, shRNA #4: V3LHS_359767, shRNA #5: V3LHS_359771) 
were supplied by the Institute for Molecular Bioscience Life Science Automation (LISA) 
Facility.  
Cell culture, transfection and generation of sortilin knockdown lines  
HeLa WT and mCherry-Rab25 stably expressing cells were maintained in DMEM 
supplemented with 10% (v/v) FCS and 2mM L-glutamine (Invitrogen) in a humidified 
air/atmosphere (5% CO2) at 37oC. Cell lines were routinely tested for mycoplasma 
contamination. Cells were seeded into 6 cm dishes and grown to 70% confluency prior to 
transfection. pGIPZ plasmids were transfected into cells using Lipofectamine 2000 as per 
manufacturer’s instruction (Invitrogen). Transfected cells were selected for using 1 µg/ml 
puromycin over a period of 14 days to generate stable cell lines expressing individual 
shRNA’s. shRNA expressing cells were subsequently cultured in growth media containing 




RNA from cells was extracted according to the manufacturer’s instructions (Sigma-Aldrich). 
1 µg of total RNA was used to produce cDNA using oligdT primers and Superscript III 
(Invitrogen). Quantitative RT-PCR was conducted using TaqMan gene expression assays for 
sortilin (SorCS1, Hs00364666_m1, Applied Biosciences) and the housekeeping gene 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Hs99999905_m1, Applied 
Biosciences). GAPDH was used as an internal control to calculate the delta cycle threshold 
(∆CT) for each sample.  
Chlamydial infection 
Chlamydia trachomatis L2 (ATCC VR-902B) and GFP-expressing Chlamydia trachomatis 
L2 were generated as described previously (Wang et al., 2011). Chlamydia was used to infect 
cells at the indicated multiplicity of infection (MOI). Cells were infected for 2 h in normal 
DMEM growth media supplemented with 10% FCS (v/v) and 2mM L-glutamine at 37oC 
humidified with 5% CO2. After which the media was replaced with fresh growth media and 
grown to the stipulated time points.  
Infectious progeny assay 
Infectious progeny assay was performed as previously described (Gonzalez et al., 2014). 
Indirect immunofluorescence 
HeLa cells grown on coverslips were transiently transfected with mammalian constructs, 
fixed and stained with indicated antibodies as described previously  (Yang et al., 2015). The 
slides were imaged using a confocal laser scanning microscope (LSM 510 Meta, Zeiss) under 
63 x magnification. Data was processed using FIJI (http://fiji.sc/Fiji) and assembled using 
Adobe Illustrator CS5. 
Western Immunoblotting 
Cell monolayers were lysed directly with SDS lysis buffer (100 mM Tris/HCL, pH 6.8, 4% 
SDS, 20% glycerol, 0.02% bromophenol blue, 200 nM dithhiothreitol). Cell lysates were 
boiled at 95oC for 10 min. Equal amounts of protein were loaded and proteins resolved on 
10% SDS-polyacrylamide gels and transferred onto Immobilon-FL PVDF membranes 
(Millipore, USA) according to the manufacturer’s instructions. Western blotting using ECL 
and Odyssey infrared imaging system (Li-Cor Biosciences) were performed as described 
previously (Yang et al., 2015). Fluorescence intensities were detected by Li-Cor Odyssey 
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Infrared Imaging System (Li-Cor Biosciences). Protein analysis and quantification was 
performed using FIJI. 
BODIPY-FL-C5-Ceramide labeling 
Cells were seeded onto glass bottom 96 well dishes (MatTek Corporation) and infected with 
C. trachomatis L2 (MOI 0.5). At 23 h p.i, the infected cells were treated with  1.25 µg/ml 
BODIPY-FL-C5-ceramide (Molecular Probes, B22650, 1:4000) as previously described 
(Pagano et al., 1991), and time-lapse videomicroscopy performed using an interval of 5 
minutes on an inverted deconvolution microscope (Nikon Ti-E deconvolution, Nikon) under 
40 x magnification  for 4 h. 
Statistical analysis 
All data are presented as mean±S.E.M. and analysed with GraphPad Prism (GraphPad 
Software). For analysis of Western immunoblots, FIJI was used to quantify protein intensity 
and analysed with GraphPad Prism. To measure the delivery of BODIPY-FL-C5-Ceramide to 
the chlamydial inclusion, 9 inclusions were measured for each replicate. For infectious 
progeny assays, 5 images were captured on a Nikon Ti-E deconvolution microscope at 10 x 
magnification and the number of inclusions quantified using FIJI. Final data represented the 
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Fig. 1: Chlamydia infection causes elevated levels of sortilin. (A) Whole cell lysates of C. 
trachomatis L2 infected HeLa cells were harvested at indicated time points. 20 μg of proteins 
were subjected to Western immunoblotting using rabbit polyclonal anti-sortilin and mouse 
monoclonal anti-beta actin antibodies followed by IR dye conjugated secondary antibodies. 
Fluorescence intensities were detected by Li-Cor Odyssey Infrared Imaging System and (B) 
quantified using FIJI demonstrating a stark increase sortilin levels during infection. Error bars 
denote mean±S.E.M., N = 2, (1-way ANOVA) * p<0.05 **p<0.005 
Fig. 2: Sortilin is associated with the inclusion throughout its development. HeLa cells 
stably expressing mCherry-Rab25 cells were infected with CTL2 (MOI 0.5) for the indicated 
time points and fixed with 4% paraformaldehyde. Samples were then immunolabeled with 
anti-sortilin antibodies and appropriate secondary antibody and counter-stained with DAPI. 
Single optical sections were obtained using a Zeiss LSM710 meta confocal microscope with 
a 63x objective. Scale bar 20 µm. 
Fig. 3: Depletion of sortilin does not impact upon delivery of ceramide to the inclusion. 
(A) The protein levels of sortilin in stable cell lines expressing non-silencing shRNA or 
shRNA targeting sortilin were analysed by western immunoblotting. (B) Sortilin knockdown 
cells were infected with CTL2 (MOI 0.5). At 23 h p.i., cells were treated with BODIPY-FL-
ceramide and delivery of ceramide followed for 4 h via live cell microscopy. Images were 
captured using a Nikon Ti-E deconvolution microscope with a 40x objective. (C) Line graph 
represent the shift in mean fluorescent intensity per inclusion analysed by Image J. At least 9 
inclusions were monitored. Error bar denote: mean±S.E.M., N=2, Scale bar 20 µm 
Fig. 4: Depletion of sortilin has no significant impact on the development of chlamydial 
infectious progeny. Control and sortilin knockdown cells were seeded onto 96 well plates, 
infected with GFP-CTL2 for 48 h. After which the cells were lysed, and lysate used to 
reinfect a new population of HeLa cells stably expressing mCherry-Rab25. 24 h p.i., cells 
were fixed and counter-stained with DAPI. Images were captured using a Nikon Ti-E 
deconvolution microscope with a 20x objective and the number of inclusions were quantified 
using Image J. Scale bar 40 µm 
Fig. 5: The level of sortilin protein within infected knockdown cells increases to that 
observed within control cells. (A) Non-silencing control and sortilin knockdown cells were 
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infected and harvested at stipulated time points. 20 μg of proteins were subjected to Western 
immunoblotting using rabbit polyclonal anti-sortilin and mouse monoclonal anti-beta actin 
antibodies followed by IR dye conjugated secondary antibodies. Fluorescent intensity 
captured by Li-Cor Odyssey Infrared Imaging System and (B) quantified using FIJI. (C) 
RNA from infected cells was extracted and prepared and quantified using Applied Science 
7500 Real Time PCR Systems. Housekeeping gene GAPDH was used as an internal control. 
Error bar denote mean±S.E.M., N=2 
Supplementary Figure S1: Rab25 is associated with the inclusion. mCherry-Rab25 stably 
expressing HeLa cells were infected with CTL2 (MOI 0.5) for 24 h before fixation with 4% 
paraformaldehyde. Samples were then immunolabeled to detect CtHtrA and counterstained 
with DAPI. Single optical sections were obtained using a Zeiss LSM710 meta confocal 
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